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Abstract: We report on the covalent immobilization of bone morphogenetic protein 6 (BMP-6) and its
co-presentation with integrin ligands on a nanopatterned platform to study cell adhesion and signaling
responses which regulate the transdifferentiation of myoblasts into osteogenic cells. To immobilize
BMP-6, the heterobifunctional linker MU-NHS is coupled to amine residues of the growth factor; this
prevents its internalization while ensuring that its biological activity is maintained. Additionally,
to allow cells to adhere to such platform and study signaling events arising from the contact to the
surface, we used click-chemistry to immobilize cyclic-RGD carrying an azido group reacting with
PEG-alkyne spacers via copper-catalyzed 1,3-dipolar cycloaddition. We show that the copresentation
of BMP-6 and RGD favors focal adhesion formation and promotes Smad 1/5/8 phosphorylation. When
presented in low amounts, BMP-6 added to culture media of cells adhering to the RGD ligands is
less effective than BMP-6 immobilized on the surfaces in inducing Smad complex activation and
in inhibiting myotube formation. Our results suggest that a local control of ligand density and cell
signaling is crucial for modulating cell response.
Keywords: integrin ligands; bone morphogenetic protein 6; surface copresentation; myotube
formation; BMP/Smad signaling
1. Introduction
Bone morphogenetic proteins (BMPs) are growth factors belonging to the TGF-β superfamily.
They exert pleiotropic effects and BMP-2 and -7 have been approved in clinical use for their potent
induction of bone formation [1]. Among the BMPs, BMP-6 is able to mediate osteogenic differentiation
and is currently tested in clinical trials in combination with an autologous blood coagulum [2,3]
showing efficacy in in vivo studies at low amounts, e.g., 50 µg in whole blood containing devices.
These doses are much lower when compared to the ones (e.g., 3.5 mg in a bovine collagen carrier)
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used for BMP-2 and -7 [4,5]. Thus, BMP-6 is an attractive candidate for future development in bone
tissue engineering.
First validated in C2C12 mouse myoblasts [6], and then further investigated in a variety of primary
human cells [7,8], the binding profile of BMP-6 to the type I (ALK-2 strongly and weakly to ALK-6)
and type II receptors, mirrors, to some extent, the one of BMP-7. While BMP-7 is emerging as a
regulator of cell adhesion and migration by modulating β-integrin activation [9] and by inducing the
expression of α5 integrins [10], the interplay between BMP-6-mediated signaling and cell adhesion
to the extracellular matrix remains largely unexplored. When combined with fibronectin, BMP-6
osteogenic activity is prolonged [11], suggesting that BMP-6 matrix interactions participate in the
regulation of cell fate. Furthermore, BMP-6 signaling activity, which results in the phosphorylation
of the Smad 1/5/8 complex, appears to be modulated by the interactions of the growth factor with
heparin. When bound to heparin, BMP-6 is able to induce osteogenic responses both in vitro and
in vivo [12]. Prediction of heparin binding sites in BMPs have identified the N-terminus region as
highly reactive [13,14]. Additionally, the binding of BMP-6 and the nature of its interactions within the
extracellular matrix make the binding of its endogenous inhibitors less effective and this in turn might
prolong its signaling [6,15–17].
Here, we developed a setup to mimic BMP-6 matrix-bound form based on the copresentation
of BMP-6 and integrin ligands (RGD, arginine-glycine-aspartic acid). The setup is based on surface
nanopatterning of gold particles by diblock copolymer micellar nanolithography surrounded by a
protein repellent layer of polyethylene glycol (PEG) [18] and functionalization with RGD ligands and
BMP-6. When bound to gold nanoparticles, the adhesive ligand is presented in ordered hexagonal
patterns at spacing ranging from 50 to 100 nm [19]. This is known to regulate integrin clustering and
favor cell adhesion for spacing ≤58 nm [20]. Alternatively, RGD is immobilized on a PEG layer at
a surface density of 1 mol% as reported in Schenk et al. [21], corresponding to a surface density of
0.53 ng/cm2. This results in disordered presentation, which may lead to a shift in spacing threshold for
cell adhesion [22]. Our aim is to determine the effects of BMP-6 and integrin-mediated adhesion on
BMP-mediated signaling and cell differentiation. We previously showed that BMP-2 immobilized via
its amine residues is still bioactive and that it signals even in nanograms to cells, due to its sustained
presentation when compared to BMP-2 added to the culture media [23,24]. In the present work, we
apply the same immobilization strategy to BMP-6 homodimers and investigate signaling in C2C12
cells. Single BMP-6 molecules are selectively immobilized on nanoparticles to control growth factor
surface density at the nanoscale. With our setup, which is based on dual functionalization chemistry for
immobilizing two different types of ligands, we achieved here spatial control over the copresentation of
growth factors and integrin ligands to study cell signaling and adhesion for BMP-6 at in low amounts.
We present a promising approach for biomaterials functionalization aiming at controlling cell fate
through adhesion at the material interface.
2. Materials and Methods
2.1. Preparation of Homogeneous Coated and Nanopatterned Surfaces
In order to produce gold homogeneous coated surfaces, clean glass coverslips (20 × 20 mm)
were coated with a 10 nm chromium layer and then a 50 nm gold layer by using a MED-020
Sputter coater (BalTec, Schalksmühle, Germany). For the nanopatterned surfaces preparation, glass
coverslips were decorated with gold nanoparticles by using block copolymer micellar nanolithography
(BCMN) as previously reported [19,20,24]. Substrates having an average interparticle distance of
32 ± 5 nm, 61 ± 9 nm and 110 ± 16 nm were used. For the 30 nm distance, gold-loaded polymer
micelle solution of 5 mg/mL polystyrene(30,000)-b-poly-2-vinylpyridine(12,500) (Polymer Source,
Quebec, Canada) in toluene with a tetrachloroauric acid to vinylpyridine monomer ratio of 0.5
was used. For 60 nm and 100 nm distances, polystyrene(110,000)-b-poly-2-vinylpyridine(52,000)
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and polystyrene(190,000)-b-poly-2-vinylpyridine(55,000) (Polymer Source) were used with the same
concentration and monomer ratio as for the 30 nm spacing.
2.2. Surface Functionalization with Integrin Ligands
In the first part of our work, in order to investigate cell spreading and FAs assembly in C2C12 cells,
gold nanopatterned surfaces with a distance of 50 nm were prepared as described above. The area
between the gold particles was passivated with PEG2000 and cyclic-RGD peptides, c(RGDfK)-thiol,
were immobilized to the gold particles. Each nanoparticle serves as binding site for only one integrin
receptor, because of its limited size (experimental setup shown in Figure 1a).
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Figure 1. Effects of BMP-6 on adhesion of C2C12 cells. (a) space between the gold nanoparticles
(interparticle distance of 50 nm) is passivated using the PEG2000, then RGD ligands carrying a -SH
group are immobilized on the nanoparticles to promote integrin-mediated cell adhesion. As control
(No BMP-6), cells were not tre ted with the growth factor. For s mples incubated with BMP-6 (sBMP-6),
the molecule was added to the media at a concent ation of 10 nM. (b) Repres ntative immunofluorescence
images of vinculin (green), nuclei (blue) and actin (red) in C2C12 cells. Cells were adhering for 4 h to
nanostructured glass surfaces without BMP-6 or with sBMP-6. Scale bar: 10 µm. (c) Cell area normalized
to the average cell area of the control samples plotted as means ± SD of at least 17 cells imaged for each
treatment in 3 independent repeats, * p < 0.001. Student’s t-test was used for comparison.
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To introduce adhesive ligands in the passivated background of the nanopapatterned surfaces
(as shown in Figure 4a), PEG2000 silane was mixed with PEG3000 silane carrying alkyne groups at
99:1 ratio. The cyclic peptide c(RGDfE)K(N3) (PSL Peptide Specialty Laboratories GmbH, Heidelberg,
Germany) was bound to the PEG layer via copper(I)-catalyzed-azide-alkyne cycloaddition as described
in [21].
2.3. Surface Immobilization of BMP-6
To immobilize BMP-6 on the substrates, gold-coated and nanopatterned glass
substrates were then incubated with a 1 mM solution of the hetero-bifunctional linker
11-mercaptoundecanoyl-N-hydroxysuccinimide ester (MU-NHS, ProChimia Surfaces, Gdynia, Poland)
in DMF for 4 h at room temperature. After sonication, the substrates were rinsed with DMF and MeOH.
Lyophilized carrier-free, glycosylated GMP-produced rhBMP-6 expressed in mammalian cells
(Genera Research, Rakov Potok, Croatia) was reconstituted in sterile 4 mM HCl to obtain a 100 µg/mL
stock solution. This solution was diluted in phosphate-buffered saline (PBS) (Gibco BRL) containing
1 M NaCl (Carl Roth) and adjusted to pH 8.5 immediately prior to use, in order to obtain a working
concentration of 3.5 µg/mL. The NHS-functionalized substrates were incubated with the BMP-6 solution
at 4 ◦C for 14 h. The surfaces were sonicated in PBS (1 M NaCl) and washed three times with the same
buffer to remove unbound proteins. The surface concentration of BMP-6 on the homogeneous surfaces
was approximately of 70–80 ng/cm2 as we previously showed for BMP-2 [23].
Concerning the nanopatterned surfaces, the amount of immobilized protein was estimated by
quantifying the average number of gold nanoparticles per µm2 from scanning electron microscopy
(SEM) images of the samples. Based on previous studies on the quantification of growth factor binding
to nanopatterned substrates [24], a coverage of approx. 90% of the particles with a single BMP-6
homodimer leads to surface density of immobilized proteins of 4.8 ng/cm2 (corresponding to an amount
of 19 ng per sample), 1.6 ng/cm2 (6.3 ng per sample) and 0.4 ng/cm2 (1.4 ng per sample), respectively,
for the different interparticle spacing (30, 50 and 100 nm).
2.4. Analysis of Surface Binding of BMP-6
Quarz crystal microbalance with dissipation monitoring (QCM-D) measurements were performed
on a Q-Sense E4 system (Q-Sense) with gold crystals (Q-sense) in an open module (Q-sense). The crystals
were functionalized with the MU-NHS linker as mentioned previously. All measurements were
performed in a volume of 200 µL and at room temperature. For the QCM-D experiments, the rinsing
consisted of buffer 1 as baseline (PBS, pH 7.4) and buffer 2 (PBS, pH 8.5, 1 M NaCl; cPBS). Then, 1 µg/mL
rhBMP-6 was incubated for 60 min in buffer 2 followed by rinsing in buffer 2 and 1 for 10 min each.
Bovine serum albumin (BSA) blocking was performed for 60 min, followed by a 30-min incubation
with anti-rhBMP-6 mouse IgG (5 µg/mL), rinsing and incubation with anti-mouse IgG (5 µg/mL).
2.5. Cell Culture
Mouse myoblasts C2C12 (ATCC CRL-1772), when grown in vitro, spontaneously fuse and
form myotubes; they transdifferentiate into cells of osteoblastic lineage in responses to BMPs [25].
C2C12 cells were cultured as subconfluent monolayers in growth medium, consisting of Dulbecco’s
modified Eagle’s medium (DMEM) (Thermo Fisher Scientific, Waltham, MA, USA) supplemented
with 10% heat inactivated fetal bovine serum (FBS) (Biochrom GmbH, Berlin, Germany) and 1%
penicillin/streptomycin (Thermo Fisher Scientific) at 37 ◦C and 5% CO2.
2.6. Western Blot Analysis of Protein Expression
Western blot analyses were performed as described in [24]. Briefly, cells were starved in serum
free DMEM for at least 5 h and then seeded at a density of 80 × 103 cells/cm2 in DMEM without
FBS. After the different time points, cells were lysed in RIPA lysis buffer (Sigma Aldrich, St. Louis,
MO, USA) containing protease inhibitors (Roche, Basel, Switzerland). Cell lysates were separated by
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SDS-PAGE, transferred to nitrocellulose membrane (Thermo Fisher Scientific) and then probed with
1:1000 rabbit anti-pSMAD 1/5/8 (Cell signaling technology, Danvers, MA, USA) and 1:2000 mouse
anti-β-actin (Sigma Aldrich) antibodies. After incubation with 1:5000 goat anti-rabbit or anti-mouse
HRP-conjugated IgG (Santa Cruz Biotechnology, Dallas, TX, USA) the detection was performed with
an ECL Plus Detection Kit and an Amersham Imager 600 (GE Healthcare, Chicago, IL, USA).
2.7. Immunostaining and Microscopy
After starving for 5 h, C2C12 cells were trypsinized and 10 × 103 cells/cm2 were seeded on
the different substrates. Control cells were not treated with the growth factor, treated cells were
exposed to surface immobilized BMP-6 (iBMP-6) or to BMP-6 added to the culture media (sBMP-6)
under low serum conditions (2% FBS). For focal adhesion staining, cells were fixed after 4 h with
4% (w/v) paraformaldehyde (PFA) in PBS. Cells were permeabilized with 0.1% (v/v) Triton-X-100 in
PBS for 5 min, washed and incubated with 1% BSA for 1 h to avoid non-specific protein binding.
The following antibodies were used: vinculin (Sigma Aldrich) 1:100, followed by anti-mouse-FITC
secondary antibody (1:100) and Phalloidin-TRITC (0.2 µg/mL) at RT in 1% BSA for 1 h. Samples were
embedded in Mowiol containing 0.1% (v/v) DAPI for an additional staining of the nucleus.
The formation of myotubes was analyzed by staining on day 4. Cells were cultured with
DMEM supplemented with 2% FBS and the media was changed after three days without adding any
additional sBMP-6. After 4 days, cells were fixed and permeabilized for immunofluorescence staining
with monoclonal anti-myosin heavy chain (MHC, MF20, Developmental Studies Hybridoma Bank,
University of Iowa; 5 µg/mL). Cells were labeled with Alexa 488 anti-mouse IgG antibody (Invitrogen,
Carlsbad, CA, USA) and DAPI solution (Sigma).
Samples were imaged by immunofluorescence microscopy (DeltaVision (DV) microscope (Applied
Precision Inc., Woodbridge, Canada; data processing controlled by Resolve 3D (Applied Precision
Inc., Issaquah, WA, USA)) equipped with a CCD camera (Olympus, Shinjuku, Tokyo, Japan) and
using a 60× oil objective for imaging of cell cytoskeleton and focal adhesions, and a 10× air objective
for imaging of myotubes. The images were adjusted in brightness and color with ImageJ software
(Research Services Branch, Image Analysis Software Version 1.52c, NIH, Bethesda, MD, USA).
2.8. Statistical Analysis
Statistical analysis was performed using the GraphPad Prism software (San Diego, CA, USA).
Groups were compared using two-sample t-test with p-values < 0.05 considered as statistically
significant (indicated as # p < 0.05, § p < 0.01, * p < 0.001). ImageJ was used to process images. Western
blot bands and myotubes area were quantified using ImageJ [26]. All plotted data show mean values
with standard deviations calculated from at least three independent experiments (samples in duplicates
or triplicates).
3. Results
3.1. BMP-6 Influences Cell Spreading and Focal Adhesion Assembly
To evaluate the influence of BMP-6 on cell adhesion and spreading, C2C12 cells were cultured for
4 h on nanopatterned surfaces presenting RGD ligands at 50 nm spacing in absence of BMP-6 (No BMP-6)
or in presence of the growth factor added to the media (sBMP-6) (Figure 1a). The 50 nm spacing has
been reported to promote cell spreading and focal adhesion assembly [20]. As expected, RGD-ligands
allowed integrin mediated cell adhesion and spreading of C2C12 cells (Figure 1b). Comparing the
formation of focal adhesions (FAs) and total cell area of samples treated or not with BMP-6 we found
that FAs were larger and increased in presence of BMP-6. Interestingly, cells in presence of both RGD
and sBMP-6 showed two-fold reduction in cell spreading (Figure 1c). This suggests that BMP-6 acts on
cell cytoskeletal tension, which is tightly couple with BMP-induced osteogenic signaling [27].
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3.2. Surface Immobilized BMP-6 is Not Internalized by Cells and Triggers Smad Signaling
To study the effect of binding proximity of integrins and BMP receptors on C2C12 adhesion
and signaling which regulate cell fate, we applied a selective chemistry approach, using a
self-assembled monolayer of the heterobifunctional linker mercaptoundecanoic-N-hydroxysuccinimide
ester (MU-NHS) to immobilize BMP-6 on gold surfaces at controlled surface density of 80 ng/cm2
as previously shown with BMP-2 [23,24,28]. We used quartz crystal microbalance with dissipation
monitoring (QCM-D) to demonstrate the validity of our platform by monitoring the binding kinetics
of BMP-6 to the MU-NHS linker and its binding specificity (Figure A1(1,2)).
To visualize the growth factor on surfaces, we detected the surface immobilized BMP-6 (iBMP-6)
by fluorescence microscopy (Figure 2a). We used four different glass coverslips (Figure 2a); in brief, a
(i) glass coated with a 50-nm homogeneous gold layer by metal sputtering (indicated as Au), (ii) glass
uncoated (indicated as Glass), (iii) glass coated with PEG (indicated as PEG), (iv) glass decorated
with 8-nm size gold nanoparticles having a spacing of 30 nm arranged in hexagonal lattice, with the
interparticle surface covered by PEG to prevent unspecific binding of protein (indicated as PEG/AuNP)
(Figure 2a). The sample was first incubated with the MU-NHS linker and then with BMP-6, followed
by detection with antibodies. Indirect immunofluorescence staining shows signal on Au, glass and
PEG/AuNP whereas on PEG coated surfaces no binding takes place, proving that PEG completely
prevents the unspecific deposition of the growth factor and antibodies on the surface, which otherwise
takes place on glass. Additionally, on PEG/AuNP, the staining for BMP-6 is rather homogeneous
in comparison to Au coated, further indicating the binding specificity of BMP-6 and the antibodies.
Furthermore, the bond between the NHS group of the linker and the amine residues of the growth
factor is stable, even after washing and further treatment with detection reagents.
We next determined the stability of the chemical bond of BMP-6 to the surface in presence of
cells (Figure 2b). C2C12 were cultured in tissue culture dishes and approached from the top [23] with
(i) glass coverslips without growth factor (control, No BMP-6), (ii) glass coverslips functionalized
with iBMP-6, (iii) glass coverslips in presence of BMP-6 added to the culture media (sBMP-6).
The surfaces were in contact to cells for different time points (30, 60 and 120 min) and detection of
remaining BMP-6 on the samples was done by chemiluminescence (Figure 2b). BMP-6 was labeled
with primary anti-BMP-6 antibody and secondary antibody conjugated with HRP, then detected by
chemiluminescence. In samples where the growth factor is absent or added to the culture media, BMP-6
is not detected neither before nor after incubation with cells. When BMP-6 is covalently immobilized on
the surface (iBMP-6), it is detected after presentation to cells, indicating that cells could not remove it.
To determine if iBMP-6 retains its biological activity, we next performed Western blotting to detect
Smad1/5/8 phosphorylation levels (Figure 2c). The activation of receptor-regulated Smads by BMP-6
converts the myogenic differentiation of C2C12 cells into osteogenic [6]. Exposing cells to control
surfaces without BMP-6 does not lead to BMP-mediated signaling. In cells exposed for 30, 60 or
120 min to 80 ng/cm2 of BMP-6 (calculated according to molecular size and weight to obtain complete
surface coverage [23]) either added to the media (sBMP-6) or immobilized on the surface (iBMP-6),
SMAD 1/5/8 is phosphorylated and no statistically significant differences can be observed between the
two groups. The peak of short term signaling, i.e., Smad 1/5/8 phosphorylation, has been reported to
be at 120 min when the growth factor is immobilized on the surfaces and at 60 min after addition of
sBMP-6 to cell cultures.
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(a) Indirect i muno-d tection of BMP-6 bound t . ff l i coating of glass
coverslips are incubated with the MU-NHS linker and BMP-6. The growth factor is detected by imaging
the binding of anti-BMP-6 tibodies and Alexa488-conjugated antibodies (fluorescence microscopy
imaging). Scale b r: 100 µm. (b) C2C 2 cells were treated from the top with gold homogeneous surfaces
in absence of BMP-6 (control, No BMP-6), in presence of covalently immobilized BMP-6 (iBMP-6) or
soluble BMP-6 (sBMP-6). BMP-6 was detected by immuno-chemiluminescence before incubation of
the surfaces with cells (before cells), and after 30, 60 and 120 min of incubation with cells. The graph
represents means ± SD of two independent repeats. (c) After 30, 60 and 120 min of incubation with
the surfaces, cell lysates were immunoblotted for pSMAD 1/5/8 and β-actin. Data are presented as
mean ± SD of three independent experiments # p < 0.05, § p < 0.01, * p < 0.001. Student’s t-test was
used for single comparison.
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3.3. Surface Copresentation of Immobilized BMP-6 and RGD Ligands Promotes Adhesion and Induces
BMP-Mediated Cell Responses
Although our system based on gold coating and self-assembled monolayer of MU-NHS linkers
allows long term studies [23], cell adhesion to the surfaces is rather unspecific and guided by deposition
of cell own matrix, which in turn mediates further signaling modulation of Smad pathways, as also
reported for other systems [29–31]. Thus, to create an adhesive background, while preserving the setup
for the presentation of iBMP-6 covalently bound to the surface, we further developed the nanopatterned
surfaces (PEG/AuNP) shown in Figure 3a by functionalizing the PEG layer with c(RGDfE)K(N3), an
integrin binding peptide. This setup is adapted from Schenk et al., where the dual functionalization
of cRGD on the gold nanoparticles and synergy peptide PHSRN on the PEG layer was developed to
promote cell adhesion [21]. Following the coating with a PEG layer consisting in a mixture of PEG2000
and PEG3000-alkyne at a 99:1 ratio, the adhesive ligand carrying an azido functional group is introduced
by copper(I)-catalyzed- azide-alkyne cycloaddition. Cells adhering to this surface were used as control
(No BMP-6). Then, the gold nanoparticles (AuNPs) were functionalized with the MU-NHS linker so that
the covalent immobilization of single BMP-6 homodimers (iBMP-6) or BMP-6 can be added to the media
in soluble form (sBMP-6) (Figure 3a). The amount of cRGD immobilized on the surface is tuned by
varying the number of functional groups in PEG [21] and the amount of BMPs on the surface by varying
the AuNPs spacing [24], to achieve a controlled spatial distribution of the peptide and the protein, and
monitor the specific response of cells to the co-presentation of biomolecule in proximity to each other.
In absence of the adhesive ligand, cells do not adhere and spread on the surfaces containing gold
nanodots with an interparticle distance of 30, 50 or 100 nm, further demonstrating the passivating
properties of the PEG layer. The functionalization with RGD peptides on the PEG3000-alkyne end
groups promotes adhesion, as indicated by the high number of spread cells on the surfaces 3 h after
seeding (Figure 3b). Regardless of the presence of BMP-6 (either added to the media or immobilized
on the surface) and the amount of immobilized BMP-6, cell adhesion and spreading was comparable
in presence of integrin ligands. This indicates that the immobilization of RGD on the PEG layer is
fundamental for early adhesion and suggests that BMP-6-mediated cell surface interactions are not
required for this process.
To study the impact of surface co-presentation of RGD and BMP-6 on cell signaling, we seeded
C2C12 cells on nanopatterned surfaces and, following lysis to extract their protein content, we monitored
Smad 1/5/8 phosphorylation by Western blotting 3 h after seeding (Figure 4).
C2C12 cells not treated with BMP-6 were used as control (No BMP-6), treated cells were exposed
to sBMP-6 (19, 6 or 1 ng) or to the corresponding amount of the immobilized growth factor (iBMP-6, at
30, 50 or 100 nm interparticle spacing). Adhesion of cells to RGD functionalized surfaces in absence of
BMP-6 does not result in Smad 1/5/8 phosphorylation, confirming the independence of Smad activation
from integrin mediated signaling. When BMP-6 is either added to the media or immobilized on the
surface, phosphorylation of Smad1/5/8 is observed. The phosphorylation kinetics and levels in cells
adhering to RGD surfaces and exposed to different concentrations of sBMP-6 indicate that signaling
takes place, but the amount of growth factor presented in the soluble form is not sufficient to trigger a
strong response on 50 and 100 nm distance surfaces. Combining RGD with iBMP-6 on the surfaces
enhances Smad phosphorylation levels with all the different nanoparticles surfaces and the highest
pSMAD 1/5/8 expression is observable with the 30 nm surfaces. It should be noted that with our
platforms we deliver here to cells 1 ng of the growth factor (when the 100 nm distance is used), which
is extremely lower than the amount typically used in standard in vitro assays (20 nM, corresponding
to 520 ng in 1 mL solution).
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Figure 4. Analysis of Smad 1/5/8 phosphorylation. (a) Lysates from C2C12 cells 3 h after seeding were
immunoblotted for pSmad1/5/8 and β-actin. (b) Smad1/5/8 phosphorylation levels were analyzed by
Western blot and quantified by measuring the intensities of protein bands normalized to β-actin levels.
Experiments were performed three times and representative images are shown, in the graphs error
bars are SD, # p < 0.05, § p < 0.01, * p < 0.001. Student’s t-test was used for single comparison.
We next investigated long-term responses of cells to iBMP-6 by imaging and quantifying myotube
formation in C2C12 cell cultures on the different surfaces detecting myosin heavy chain (MHC)
(Figure 5a,b). In cells cultured for 6 days on Au homogeneous surfaces (Figure 5a), staining for myosin
heavy chain reveals the presence of myotubes (Figure 5a, No BMP-6). When BMP-6 is either covalently
immobilized on the Au surface (iBMP-6) or added to the culture media (sBMP-6), it suppresses
myotube formation. Thus, iBMP-6 maintains its short- and long-term biological activity. The effective
immobilization of BMP-6 on material surfaces, showing that the growth factor is still active even after
a longer period of time, has not been reported thus far.
To determine the long-term effects of RGD-iBMP-6 surfaces, we cultured C2C12 cells for 4 days
and performed immunofluorescence microscopy studies of myotube formation by detecting myosin
heavy chain (MHC) (Figure 5b). In the control group, cells were left to adhere and further cultured on
nanopatterned surfaces with clicked RGD, but in absence of BMP-6 (Figure 5b left). For the iBMP-6 and
sBMP-6 groups, cells were additionally exposed to 19, 6 or 1 ng of the growth factor, either covalently
immobilized on the surface (Figure 5b middle) or added to the culture media (Figure 5b right). C2C12
cells form myotubes in the control group as evidenced by the green staining for MHC; in presence of
iBMP-6 and sBMP-6, MHC positive myotubes formation is significantly prevented when the factor
is added at an amount of 19 ng. This inhibitory effect on myotubes formation decreases with the
reduction of BMP-6 concentration used (Figure 5b). In particular, for 1 ng of sBMP-6, corresponding
to the amount presented at 100 nm spacing, iBMP-6 is more effective than sBMP-6, suggesting that
the sustained presentation of the growth factor, activates signaling pathways even after several days
in culture. As such, surface copresentation of low amounts of BMP-6 together with integrin ligands
guides cell fate through adhesion and regulation of signaling.
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Figure 5. Analysis of myotubes formation in C2C12 cells. Cells were seeded on gold
homogeneous surfaces (a) or nanopatterned surfaces (b) and cultured to allow myotube formation.
Immunofluorescence microscopy images show myosin heavy chain (MHC) staining of multinucleated
myotubes (green) and DAPI nuclei staining (blue). Myotube formation is observed when cells are
cultured on control surfaces in absence of BMP-6 (No BMP-6). For iBMP-6 and sBMP-6, cells were
cultured in presence of 80 ng (A) or 19, 6 and 1 ng (B) of the growth factor. MHC positive areas were
quantified by image analysis. In the graphs error bars are SD, # p < 0.05, § p < 0.01, * p < 0.001. Student’s
t-test was used for single comparison.
4. Discussion
The objective of this study was to develop surfaces containing controlled density of immobilized
BMP-6 and co-present it with RGD ligands to direct cell adhesion and signaling. Cell adhesion and
spreading were key elements to investigate cell differentiation and tissue repair. Several studies have
demonstrated that cyclic RGD peptides promote osteogenic differentiation, especially when they
participate in BMP-mediated signaling [32–34]. Focusing on early adhesion processes, we found that
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the presence of RGD ligands induced peripheral clustering of vinculin leading to the formation of FAs
in C2C12 cells. Moreover, when BMP-6 was added to the media, cells displayed larger FAs and smaller
dimensions, if compared to the control ones.
FAs assembly and cell spreading are both mediated by integrins, transmembrane receptors, whose
cross-talk with BMPs has been investigated at several levels showing the involvement of this growth
factor family in cell adhesion and migration as well as reorganization of the cytoskeleton [23,30].
In comparison to soluble BMPs the immobilization systems have the advantage of controlled and
sustained influence on cell behavior, altering signaling kinetics or activating alternative signaling
pathways, with consequent enhanced biological activity and stability [29,35,36]. To take advantage of
the features related to growth factor presented in matrix-bound form, we immobilized BMP-6 through
a heterobifunctional linker which still allows the interaction of the growth factor with its receptors.
We first immobilized BMP-6 on surfaces homogeneously covered with gold and proved its stability and
preservation of its biological properties looking at the activation of the Smad signaling pathway and
the inhibition of myotube formation. Afterwards we immobilized the growth factor on nanopatterned
surfaces decorated with gold nanoparticles spaced at 30, 50 or 100 nm to control BMP-6 amount and
exact number of immobilized molecules [24]. Our data indicate that when BMP-6 is immobilized
on the surfaces it is able to induce short-term signaling pathways through the phosphorylation of
Smad1/5/8 and it is also still active after 4 days of culture inhibiting myotube formation. We found that
BMP-6 application is significantly effective even at amounts as low as 1 ng.
The results are consistent with our previous works on BMP-2 [23,24], in which we showed the
activation of short and long-term signaling pathways by the immobilized growth factor. Nevertheless,
the present study goes forward, since it combines the immobilization strategy with the presentation of
adhesive molecules which in turn allow cell adhesion and it also identifies in BMP-6 an application
full of promises. Among the BMPs, BMP-6 usage has not yet been explored enough, but it has been
demonstrated to be more efficacious in inducing osteoblast differentiation in vitro, bone formation
in vivo and also to be more resistant to Noggin inhibition if compared to BMP-7 [15].
Concerning the immobilization of the BMPs, several methods have been reported for their
immobilization, mainly involving BMP-2 [28] and BMP-7 full proteins and short peptide sequences,
on material surfaces [36,37]. More recently, site-specific modification of recombinant human BMP-2
for the covalent binding to a linker via click chemistry was immobilized to NeutrAvidin-agarose
beads [38]. While our strategy does not allow a precise control over the orientation of the molecule, it
however ensures the specific binding of growth factors on the surface without further modification of
active residues of the protein. Compared to homogenously coated gold substrates, the nanopatterned
surfaces allowed the copresentation of adhesion ligands addressing integrins. Regarding the integrin
types, which might cooperate with BMP-6 in signaling pathways, results from different studies on
BMP-2 show the possible involvement of β1 integrins, when adhesion is promoted by ECM present in
the system [29,39], whereas β3 integrins appear to be involved in the crosstalk when integrin-mediated
adhesion relies on the endogenous production of ECM by the cells cultured on the materials [30].
Addressing integrin specificity and the crosstalk with BMPs in C2C12 is of particular interest for
differentiation studies on regenerative muscle, being β3 integrin upregulation required for myotube
formation during C2C12 differentiation [40]. Therefore, it. would be interesting in future studies to
define how BMP-mediated and β3 integrin-mediated signaling are finely regulated for myogenic or
osteogenic differentiation. In a recent study, to mimic the cell environment and determine the effect of
RGD and BMP-2 mimetic peptide crosstalk, the two ligands have been presented at varying surface
concentrations to human bone marrow mesenchymal stem cells to trigger adhesion and osteogenic
differentiation [33]. Thus, the results presented here could be also extended in the future to further
stimulate osteogenic differentiation of mesenchymal stem cells and improve the coatings of artificial
materials for treatment of bone defects. Moreover, our innovative approach may provide a basis for a
better understanding of several biological questions related to cell response and cell fate to co-presented
factors at the nanoscale, which could be interesting for biomaterial engineering in future.
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5. Conclusions
In this work, we developed a platform for the copresentation of growth factors, namely BMP-6,
and the integrin binding RGD peptide to modulate cell adhesion and signaling responses. Both
extracellular ligands are covalently immobilized to prevent internalization, and therefore, achieve
their sustained presentation to cells. Moreover, using surface nanopatterning, we immobilized BMP-6
and RGD in amounts as low as 1 ng, while maintaining their biological activity. Our results suggest
that a local control of signals and density of ligands is crucial for modulating cell response. To our
knowledge, this is the first platform that is based on the covalent immobilization of recombinant
human BMP-6 and which studies the effects of this growth factor on integrin-mediated adhesion
in differentiation. In future studies, the molecular mechanisms should be addressed, in particular
regarding the regulation of lineage commitment and differentiation of cells.
Author Contributions: Conceptualization, E.A.C.-A., A.L.G. and F.P.; formal analysis, A.L.G., F.P., V.M. and
E.A.C.-A.; funding acquisition, E.A.C.-A., A.S. and S.V.; investigation, A.L.G., F.P. and V.M.; methodology, A.L.G.,
F.P., V.M. and G.M.; project administration: E.A.C.-A.; resources, E.A.C.-A. and S.V.; supervision, E.A.C.-A., G.M.
and D.H.; visualization, A.L.G. and F.P.; writing—original draft preparation, E.A.C.-A., A.L.G., F.P., G.M. and S.V.;
writing—review and editing, all coauthors.
Funding: This research was funded by grants from the German Science Foundation—project number
107540325—SFB TRR 79 project M09 (E.A.C.-A., A.S.) and B05 (E.A.C.-A.) and by the Max Planck Society.
Acknowledgments: The authors thank the members of the Department of Cellular Biophysics of the Max
Planck Institute for Medical Research and of the Department of Biophysical Chemistry of the Institute of Physical
Chemistry (Heidelberg University). In particular the authors thank Federica Pennarola for support and discussions.
GMP clinical batch rhBMP-6 was produced by Genera Research (Rakov Potok, Croatia) for the FP7 HEALTH
funded project Osteogrow (Grant Agreement No. 279239) which is currently tested in patients with distal radius
fracture and high tibial osteotomy.
Conflicts of Interest: The authors declare that the research was conducted in the absence of any commercial or
financial relationships that could be construed as a potential conflict of interest.
Appendix A
We functionalized the gold-electrode of the QCM-D crystals with the MU-NHS linker and the
binding of BMP-6 was monitored in situ with QCM-D. The frequency and dissipation profiles shown in
Figure A1(1,2) (blue and red lines) indicate that BMP-6 binds to the gold electrode of the QCM crystal,
which was functionalized with the MU-NHS. The saturation of the BMP-6 binding events to MU-NHS
linker is indicated by a slowdown of the kinetic and a total frequency shift of 8 Hz. Incubating the
crystal with equilibrating buffers keeps the frequency constant and thus does not result in significant
removal of the growth factor from the surface. The same holds true for addition of BSA, which does
not lead to an additional shift (Figure A1(1)), suggesting that the underlying gold surface and the free
NHS groups are blocked. For the negative control we used sampled without addition of BMP-6 to
the sensor surface and exposed them to an equivalent amount of BSA. Addition of BSA resulted in a
frequency shift, which indicates its binding to the free active ester groups of the linker (Figure A1(2))
due to absence of BMP-6. Anti-BMP-6 antibodies were added to surfaces previously incubated with
BMP-6, and their binding was monitored, which resulted in a final shift of 7 Hz, whereas in absence of
the growth factors, no binding took place (0.3 Hz frequency shift).
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Figure A1. Detection of binding kinetics of BMP-6 to gold surface via the MU-NHS linker. (1 and
2) QCM frequency and dissipation monitoring of BMP-6 binding to gold coated quartz crystals over
time. Gold coated QCM crystals presenting the MU-NHS linker are (1) incubated with BMP-6 and then
blocked with BSA or (2) blocked with BSA alone. The presence of the growth factor is further validated
by the binding of anti-BMP-6 antibody.
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